Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the ...

Maria welcomes Dr. Anna Lembke MD, Professor & Medical Director of Addiction Medicine at Stamford University to discuss ...

Researchers have discovered two new brain pathways that modify movement and emotional decisions by controlling dopamine ...

This agent, which combines xanomeline and trospium, doesn’t involve dopamine receptor blockade. “It will be very interesting ...

Researchers at the University of Pittsburgh have recently uncovered insights into how specific brain pathways influence cocaine addiction. The study, published in Neuropharmacology, found that ...

For many people, Adderall is highly effective at managing ADHD symptoms. Unlike Desoxyn, Adderall is available in ...

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...

Lyu X, Li Z, Chen S, et al. Transcranial direct current stimulation improves tardive dyskinesia in long-term hospitalized patients with chronic schizophrenia. Clin Neurophysiol. 2024;166:20-30. doi:10 ...

BENGALURU: Parkinson’s disease (PD) has no cure, and the symptoms get worse as the disease progresses with the patient age.

Opens in a new tab or window In 2024, several research and pharmacological advancements were made for tardive dyskinesia, a ...